Dr. Louis Aronne, MD, FACP, Chief Medical Officer of Intellihealth and medical director of the Comprehensive Weight Control Center at Weill Cornell, discusses the latest medical obesity treatment: Intellihealth’s Evolve — a technology platform for medically-supervised weight management.
Louis J. Aronne, MD, FACP is a leading authority on obesity and its treatment. He is the Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College and directs the Center for Weight Management and Metabolic Clinical Research, a state-of-the-art, multidisciplinary obesity research and treatment program. He has an adjunct appointment at Columbia University College of Physicians and Surgeons. Dr. Aronne is Founder and CEO of BMIQ, a weight control program that is delivered by health care providers to their patients during office visits. Dr. Aronne graduated Phi Beta Kappa from Trinity College with a BS in biochemistry and from Johns Hopkins University School of Medicine. He completed his internship and residency at Albert Einstein College of Medicine and the Bronx Municipal Hospital Center, followed by a Henry J. Kaiser Family Foundation Fellowship at New York Hospital-Cornell Medical Center. He is a member of the Alpha Omega Alpha Medical Honor Society. Dr. Aronne is former president of the Obesity Society and a Fellow of the American College of Physicians. Vice-chairman of the board of the American Board of Obesity Medicine, he has authored more than 60 papers and book chapters on obesity and edited the National Institutes of Health Practical Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. He served as a consultant to the VA Weight Management/Physical Activity Executive Council in the development of the MOVE program, the nation’s largest medically based weight control program. Dr. Aronne has won several awards for medical teaching, including the Davidoff Prize from Albert Einstein College of Medicine and the Elliot Hochstein Award from Cornell University.